Cover
Cover - shares | 6 Months Ended | |
Sep. 30, 2023 | Nov. 03, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-08762 | |
Entity Registrant Name | ITERIS, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 95-2588496 | |
Entity Address, Address Line One | 1250 S. Capital of Texas Hwy., Building 1 | |
Entity Address, Address Line Two | Suite 330 | |
Entity Address, City or Town | Austin | |
Entity Address, State or Province | TX | |
Entity Address, Postal Zip Code | 78746 | |
City Area Code | 512 | |
Local Phone Number | 382-9669 | |
Title of 12(b) Security | Common Stock, $0.10 par value | |
Trading Symbol | ITI | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 42,822,803 | |
Entity Central Index Key | 0000350868 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --03-31 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q2 |
Unaudited Condensed Balance She
Unaudited Condensed Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 20,161 | $ 16,587 |
Restricted cash | 449 | 140 |
Trade accounts receivable, net of allowance for doubtful accounts of $360 and $357 at September 30, 2023 and March 31, 2023, respectively | 24,929 | 23,809 |
Unbilled accounts receivable | 8,562 | 8,349 |
Inventories | 10,781 | 10,841 |
Prepaid expenses and other current assets | 4,079 | 3,128 |
Total current assets | 68,961 | 62,854 |
Property and equipment, net | 1,325 | 1,297 |
Right-of-use assets | 7,509 | 8,345 |
Intangible assets, net | 9,968 | 10,190 |
Goodwill | 28,340 | 28,340 |
Other assets | 502 | 768 |
Total assets | 116,605 | 111,794 |
Current liabilities: | ||
Trade accounts payable | 14,942 | 12,943 |
Accrued payroll and related expenses | 10,837 | 12,923 |
Accrued liabilities | 5,654 | 5,453 |
Deferred revenue | 7,322 | 6,720 |
Total current liabilities | 38,755 | 38,039 |
Lease liabilities | 6,560 | 7,641 |
Deferred income taxes | 463 | 422 |
Unrecognized tax benefits | 37 | 79 |
Other long-term liabilities | 3,224 | 2,707 |
Total liabilities | 49,039 | 48,888 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred stock, $1.00 par value: Authorized shares — 2,000 Issued and outstanding shares — none | 0 | 0 |
Common stock, $0.10 par value: Authorized shares - 70,000 at June 30, 2023 and March 31, 2023 Issued and outstanding shares — 42,646 and 42,346, respectively, at June 30, 2023 and 42,416 and 42,416, respectively, at March 31, 2023 | 4,283 | 4,282 |
Treasury stock | (9) | (891) |
Additional paid-in capital | 192,037 | 190,082 |
Accumulated deficit | (128,745) | (130,567) |
Total stockholders' equity | 67,566 | 62,906 |
Total liabilities and stockholders' equity | $ 116,605 | $ 111,794 |
Common stock, outstanding (in shares) | 42,823,000 | 42,808,000 |
Unaudited Condensed Balance S_2
Unaudited Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Trade accounts receivable, allowance for doubtful accounts | $ 360 | $ 357 |
Preferred stock, par value (in dollars per share) | $ 1 | $ 1 |
Preferred stock, authorized (in shares) | 2,000,000 | 2,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.10 | $ 0.10 |
Common stock, authorized (in shares) | 70,000,000 | 70,000,000 |
Common stock, issued (in shares) | 42,823,000 | 42,808,000 |
Common stock, outstanding (in shares) | 42,823,000 | 42,808,000 |
Unaudited Condensed Statements
Unaudited Condensed Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Total revenues | $ 43,563 | $ 39,259 | $ 87,108 | $ 72,926 |
Cost of revenues | 27,299 | 32,708 | 54,041 | 56,216 |
Gross profit | 16,264 | 6,551 | 33,067 | 16,710 |
Operating expenses: | ||||
General and administrative | 6,344 | 4,978 | 12,145 | 11,405 |
Sales and marketing | 6,236 | 5,674 | 12,526 | 10,872 |
Research and development | 2,565 | 2,173 | 4,673 | 4,309 |
Amortization of intangible assets | 651 | 651 | 1,302 | 1,319 |
Restructuring charges | 0 | 0 | 0 | 707 |
Total operating expenses | 15,796 | 13,476 | 30,646 | 28,612 |
Operating income (loss) | 468 | (6,925) | 2,421 | (11,902) |
Non-operating income (expense): | ||||
Other income, net | 48 | 117 | 247 | 94 |
Interest income (expense), net | 2 | (300) | 70 | (332) |
Income (loss) before income taxes | 518 | (7,108) | 2,738 | (12,140) |
Benefit from (provision for) income taxes | 33 | (289) | (62) | (122) |
Net income (loss) | $ 551 | $ (7,397) | $ 2,676 | $ (12,262) |
Net income (loss) per common share | ||||
Basic net income (loss) per share (in dollars per share) | $ 0.01 | $ (0.17) | $ 0.06 | $ (0.29) |
Diluted net income (loss) per share (in dollars per share) | $ 0.01 | $ (0.17) | $ 0.06 | $ (0.29) |
Shares used in basic per share calculations (in shares) | 42,742,000 | 42,288,000 | 42,654,000 | 42,334,000 |
Shares used in diluted per share calculations (in shares) | 43,713,000 | 42,288,000 | 43,677,000 | 42,334,000 |
Product | ||||
Total revenues | $ 23,398 | $ 20,788 | $ 47,056 | $ 37,169 |
Cost of revenues | 13,086 | 20,026 | 25,190 | 31,683 |
Service | ||||
Total revenues | 20,165 | 18,471 | 40,052 | 35,757 |
Cost of revenues | $ 14,213 | $ 12,682 | $ 28,851 | $ 24,533 |
Unaudited Condensed Statement_2
Unaudited Condensed Statements of Cash Flows - USD ($) $ in Thousands | 6 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash flows from operating activities | ||
Net income (loss) | $ 2,676 | $ (12,262) |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
Right-of-use asset non-cash expense | 1,027 | 2,122 |
Deferred income taxes | (1) | 14 |
Depreciation of property and equipment | 286 | 308 |
Stock-based compensation | 1,396 | 1,544 |
Amortization of intangible assets | 1,570 | 1,626 |
Changes in operating assets and liabilities: | ||
Trade accounts receivable | (1,120) | (912) |
Unbilled accounts receivable and deferred revenue | 906 | (1,320) |
Inventories | 60 | (4,894) |
Prepaid expenses and other assets | (685) | 503 |
Trade accounts payable and accrued expenses | (199) | 1,123 |
Operating lease liabilities | (1,182) | (1,486) |
Net cash provided by (used in) operating activities | 4,734 | (13,634) |
Net cash used in operating activities - discontinued operations | 0 | (329) |
Net cash provided by (used in) operating activities | 4,734 | (13,963) |
Cash flows from investing activities | ||
Purchases of property and equipment | (314) | (378) |
Capitalized software development costs | (1,125) | (670) |
Net cash used in investing activities | (1,439) | (1,048) |
Cash flows from financing activities | ||
Proceeds from stock option exercises | 344 | 45 |
Proceeds from ESPP purchases | 268 | 232 |
Tax withholding payments for net share settlements of restricted stock units | (24) | (59) |
Repurchases of common stock | 0 | (884) |
Net cash provided by (used in) financing activities | 588 | (666) |
Increase (decrease) in cash, cash equivalents and restricted cash | 3,883 | (15,677) |
Cash, cash equivalents and restricted cash at beginning of period | 16,727 | 23,809 |
Cash, cash equivalents and restricted cash at end of period | 20,610 | 8,132 |
Supplemental schedule of non-cash investing and financing activities: | ||
Lease liabilities arising from obtaining right-of-use assets | 128 | 155 |
Capitalized software development costs in accounts payable and accrued liabilities | $ 466 | $ 0 |
Unaudited Condensed Statement_3
Unaudited Condensed Statements of Stockholders’ Equity - USD ($) $ in Thousands | Total | Common Stock | Treasury Stock | Additional Paid-In Capital | Accumulated Deficit |
Balance (in shares) at Mar. 31, 2022 | 42,416,000 | ||||
Balance, treasury stock (in shares) at Mar. 31, 2022 | 0 | ||||
Balance at Mar. 31, 2022 | $ 75,250 | $ 4,242 | $ 0 | $ 186,720 | $ (115,712) |
Increase (Decrease) in Stockholders' Equity | |||||
Stock option exercises (in shares) | 1,000 | ||||
Stock option exercises | 1 | 1 | |||
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes (in shares) | 4,000 | ||||
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes | 24 | 24 | |||
Stock-based compensation | 848 | 848 | |||
Treasury stock purchases (in shares) | 300,000 | ||||
Treasury stock purchases | (884) | $ (884) | |||
Net income (loss) | (4,865) | (4,865) | |||
Balance (in shares) at Jun. 30, 2022 | 42,421,000 | ||||
Balance, treasury stock (in shares) at Jun. 30, 2022 | 300,000 | ||||
Balance at Jun. 30, 2022 | 70,374 | $ 4,242 | $ (884) | 187,593 | (120,577) |
Balance (in shares) at Mar. 31, 2022 | 42,416,000 | ||||
Balance, treasury stock (in shares) at Mar. 31, 2022 | 0 | ||||
Balance at Mar. 31, 2022 | 75,250 | $ 4,242 | $ 0 | 186,720 | (115,712) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | (12,262) | ||||
Balance (in shares) at Sep. 30, 2022 | 42,640,000 | ||||
Balance, treasury stock (in shares) at Sep. 30, 2022 | 300,000 | ||||
Balance at Sep. 30, 2022 | 63,866 | $ 4,265 | $ (884) | 188,459 | (127,974) |
Balance (in shares) at Jun. 30, 2022 | 42,421,000 | ||||
Balance, treasury stock (in shares) at Jun. 30, 2022 | 300,000 | ||||
Balance at Jun. 30, 2022 | 70,374 | $ 4,242 | $ (884) | 187,593 | (120,577) |
Increase (Decrease) in Stockholders' Equity | |||||
Stock option exercises (in shares) | 27,000 | ||||
Stock option exercises | 44 | $ 3 | 41 | ||
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes (in shares) | 108,000 | ||||
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes | (83) | $ 11 | (94) | ||
Stock-based compensation | 696 | 696 | |||
Issuance of shares pursuant to Employee Stock Purchase Plan (in shares) | 84,000 | ||||
Issuance of shares pursuant to Employee Stock Purchase Plan | 232 | $ 9 | 223 | ||
Net income (loss) | (7,397) | (7,397) | |||
Balance (in shares) at Sep. 30, 2022 | 42,640,000 | ||||
Balance, treasury stock (in shares) at Sep. 30, 2022 | 300,000 | ||||
Balance at Sep. 30, 2022 | $ 63,866 | $ 4,265 | $ (884) | 188,459 | (127,974) |
Balance (in shares) at Mar. 31, 2023 | 42,808,000 | 42,808,000 | |||
Balance, treasury stock (in shares) at Mar. 31, 2023 | 369,000 | ||||
Balance at Mar. 31, 2023 | $ 62,906 | $ 4,282 | $ (891) | 190,082 | (130,567) |
Increase (Decrease) in Stockholders' Equity | |||||
Stock option exercises (in shares) | 60,000 | ||||
Stock option exercises | 257 | $ 6 | 251 | ||
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes (in shares) | 1,000 | ||||
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes | (6) | (6) | |||
Stock-based compensation | 525 | 525 | |||
Net income (loss) | 2,125 | 2,125 | |||
Balance (in shares) at Jun. 30, 2023 | 42,869,000 | ||||
Balance, treasury stock (in shares) at Jun. 30, 2023 | 369,000 | ||||
Balance at Jun. 30, 2023 | $ 65,807 | $ 4,288 | $ (891) | 190,852 | (128,442) |
Balance (in shares) at Mar. 31, 2023 | 42,808,000 | 42,808,000 | |||
Balance, treasury stock (in shares) at Mar. 31, 2023 | 369,000 | ||||
Balance at Mar. 31, 2023 | $ 62,906 | $ 4,282 | $ (891) | 190,082 | (130,567) |
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | $ 2,676 | ||||
Balance (in shares) at Sep. 30, 2023 | 42,823,000 | 42,823,000 | |||
Balance, treasury stock (in shares) at Sep. 30, 2023 | 91,000 | ||||
Balance at Sep. 30, 2023 | $ 67,566 | $ 4,283 | $ (9) | 192,037 | (128,745) |
Balance (in shares) at Jun. 30, 2023 | 42,869,000 | ||||
Balance, treasury stock (in shares) at Jun. 30, 2023 | 369,000 | ||||
Balance at Jun. 30, 2023 | 65,807 | $ 4,288 | $ (891) | 190,852 | (128,442) |
Increase (Decrease) in Stockholders' Equity | |||||
Stock option exercises (in shares) | 44,000 | ||||
Stock option exercises | 87 | $ 4 | 83 | ||
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes (in shares) | 78,000 | ||||
Issuance of shares pursuant to vesting of restricted stock units, net of payroll withholding taxes | (4) | $ 8 | (12) | ||
Issuance of shares pursuant to vesting of performance stock units, net of payroll withholding taxes (in shares) | 40,000 | ||||
Issuance of shares pursuant to vesting of performance stock units, net of payroll withholding taxes | (14) | $ 4 | (18) | ||
Treasury stock retirement | 0 | $ (30) | $ 884 | (854) | |
Treasury stock retirement (in shares) | (300,000) | (300,000) | |||
Deferred shares held within rabbi trust (in shares) | 22,000 | ||||
Deferred shares held within rabbi trust | 0 | $ (2) | 2 | ||
Stock-based compensation | 871 | 871 | |||
Issuance of shares pursuant to Employee Stock Purchase Plan (in shares) | 92,000 | ||||
Issuance of shares pursuant to Employee Stock Purchase Plan | 268 | $ 9 | 259 | ||
Net income (loss) | $ 551 | 551 | |||
Balance (in shares) at Sep. 30, 2023 | 42,823,000 | 42,823,000 | |||
Balance, treasury stock (in shares) at Sep. 30, 2023 | 91,000 | ||||
Balance at Sep. 30, 2023 | $ 67,566 | $ 4,283 | $ (9) | $ 192,037 | $ (128,745) |
Description of Business and Sum
Description of Business and Summary of Significant Accounting Policies | 6 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business and Summary of Significant Accounting Policies | Description of Business and Summary of Significant Accounting Policies Description of Business Iteris, Inc. (referred to collectively in this report as "Iteris", the "Company", "we", "our", and "us") is a provider of smart mobility infrastructure management solutions. Our cloud-enabled solutions help public transportation agencies, municipalities, commercial entities and other transportation infrastructure providers monitor, visualize, and optimize mobility infrastructure to make mobility safe, efficient and sustainable for everyone. As a pioneer in intelligent transportation systems ("ITS") technology, our intellectual property, advanced detection sensors, mobility and traffic data, software-as-a-service ("SaaS") offerings, mobility consulting services, and cloud-enabled managed services represent a comprehensive range of smart mobility infrastructure management solutions that we distribute to customers throughout the United States ("U.S.") and internationally. We believe our products, solutions and services increase vehicle and pedestrian safety and decrease congestion within our communities, while also reducing environmental impact, including carbon emissions. We continue to make significant investments to leverage our existing technologies and further enhance our advanced detection sensors, software as a service portfolio, mobility data sets, mobility consulting services, and cloud-enabled managed services. As we are always mindful of capital allocation, we apply significant effort to evaluate and prioritize these investments. Likewise, we are always exploring strategic alternatives intended to optimize the value of our Company. Iteris was incorporated in Delaware in 1987 and has operated in its current form since 2004. Our principal executive offices are located at 1250 S Capital of Texas Hwy, Bldg. 1, Suite 330, Austin TX 78746, and our telephone number at that location is (512) 716-0808. Our website address is www.iteris.com. The inclusion of our website address in this report does not include or incorporate by reference into this report any information on, or accessible through, our website. Each of our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, together with amendments to these reports, are available on the "Investor Relations" section of our website, free of charge, as soon as reasonably practicable after such material is filed with, or furnished to, the U.S. Securities and Exchange Commission ("SEC"). Recent Developments COVID-19 Update The World Health Organization determined that COVID-19 no longer fits the definition of a public health emergency and the U.S. government announced that the declaration of a public health emergency associated with COVID-19 expired on May 11, 2023. Although COVID-19 has entered an endemic stage, the continuing impacts of COVID-19 remain and are expected to continue to remain as a serious endemic threat for an indefinite future period and COVID-19 (or other future pandemics) may continue to adversely affect the global economic conditions, including possible additional supply chain disruptions, workplace dislocations, economic contraction, and negative pressure on customer budgets and customer sentiment. Given the uncertainties surrounding the impacts of COVID-19 on the Company's future financial condition and results of operations, we have and may continue to identify and execute various actions to preserve our liquidity, manage cash flow and strengthen our financial flexibility. Such actions include, but are not limited to, reducing our discretionary spending, reducing capital expenditures, and implementing restructuring activities (see Note 3, Restructuring Activities , to the Financial Statements for more information). Our products require specialized parts, some of which became more difficult to source during the COVID-19 pandemic. In some cases, we had to purchase such parts from third-party brokers at substantially higher prices. The Company's tactics to mitigate global supply chain issues included re-designing certain circuit boards to accommodate computer chips that are more readily available in the market at more reasonable prices, and accumulating inventory in the first two quarters of the fiscal year ended March 31, 2023 ("Fiscal 2023"). We also placed non-cancellable inventory orders for certain products in advance of our normal lead times to secure normal and incremental future supply and capacity. The increase in inventory purchases and in particular components purchased in the secondary markets was curtailed in the second half of Fiscal 2023, and the Company currently does not expect to continue to accumulate inventory, in the same magnitude, in future periods. However, if the Company encounters additional supply chain constraints again in the future, it may need to further adjust its operations to maintain sufficient liquidity. Restructuring Activities To help offset increases in supply chain costs in Fiscal 2023, on May 12, 2022, the Board of Directors of Iteris, Inc. approved additional restructuring activities to better position the Company for increased profitability and growth. The Company incurred employee separation costs in relation to these activities, which were included in restructuring charges on the unaudited condensed statement of operations. Refer to Note 3, Restructuring Activities , for more information. Basis of Presentation Our unaudited condensed financial statements have been prepared in accordance with the rules of the SEC for interim reporting, which permit certain footnotes or other financial information that are normally required by generally accepted accounting principles in the U.S. (“GAAP”) to be condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and related notes included in its Annual Report on Form 10-K for Fiscal 2023, filed with the SEC on June 29, 2023. All intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the three and six months ended September 30, 2023 are not necessarily indicative of the results to be expected for fiscal year ended March 31, 2024 ("Fiscal 2024") or any other future periods. Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires our management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and reported amounts of revenues and expenses during the reporting period. Significant estimates made in the preparation of the financial statements include, but are not limited to, recoverability of long-lived and intangible assets; estimates of future cash flows used to assess the recoverability of the impairment of goodwill; collectability of accounts receivable; projections of taxable income used to assess realizability of deferred tax assets; warranty reserves; costs to complete long-term contracts; indirect cost rates used in cost plus contracts; fair value of stock option awards and equity instruments; capitalization and estimated useful life of the Company's internal-use software development costs. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. However, future events are subject to change and best estimates and judgments may require further adjustments, therefore, actual results could differ materially from those estimates. Management periodically evaluates such estimates and they are adjusted prospectively based upon such evaluation. Revenue Recognition The Company recognizes revenues when control of the promised goods or services are transferred to our customers, in an amount that reflects the consideration that we expect to be entitled to in exchange for those goods or services. We generate all of our revenue from contracts with customers, ranging from purchase orders to multi-year agreements. Product revenue related contracts with customers begin when we acknowledge a purchase order for a specific customer order of product to be delivered in the near term. These purchase orders are generally short-term in nature. Product revenue is recognized at a point in time upon shipment or upon customer receipt of the product, depending on shipping terms. The Company determined that this method best represents the transfer of goods as transfer of control typically occurs upon shipment or upon customer receipt of the product. Service revenues consist of revenues derived from maintenance support contracts and subscription agreements for the use of the Company’s service platforms and Application Programming Interfaces ("API's"). We generate this revenue from fees for maintenance and support, monthly active user fees, SaaS fees, and hosting and storage fees. In most cases, the subscription or transaction arrangement is a single performance obligation comprised of a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service). The Company applies a time-based measure of progress to the total transaction price, which results in ratable recognition over the term of the contract. The Company determined that this method best represents the transfer of services as the customer obtains equal benefit from the service throughout the service period. Service revenues are also derived from long-term engineering and consulting service contracts, primarily with governmental agencies. These contracts generally include performance obligations in which control is transferred over time. We recognize revenue on fixed fee contracts over time, using the proportion of actual costs incurred to the total costs expected to complete the contract performance obligation. The Company determined that this method best represents the transfer of services as the proportion closely depicts the efforts or inputs completed towards the satisfaction of a fixed fee contract performance obligation. Time & Materials (“T&M”) and Cost Plus Fixed Fee (“CPFF”) contracts are considered to involve variable consideration. However, contractual performance obligations with these fee types qualify for the “Right to Invoice” practical expedient. Under this practical expedient, the Company is allowed to recognize revenue over time, in the amount to which the Company has a right to invoice. In addition, the Company is not required to estimate such variable consideration upon inception of the contract and reassess the estimate each reporting period. The Company determined that this method best represents the transfer of services as, upon billing, the Company has a right to consideration from a customer in an amount that directly corresponds with the value to the customer of the Company’s performance completed to date. The Company accounts for individual goods and services separately if they are distinct performance obligations, which often requires significant judgment based upon knowledge of the products and/or services, the solution provided and the structure of the sales contract. In SaaS agreements, we provide a service to the customer that combines the software functionality, maintenance and hosting into a single performance obligation. In product-related contracts, a purchase order may cover different products, each constituting a separate performance obligation. We generally estimate variable consideration at the most likely amount to which we expect to be entitled and in certain cases based on the expected value, which requires judgment. We include estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Our estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of our anticipated performance and all information (historical, current and forecasted) that is reasonably available to us. We review and update these estimates on a quarterly basis. The Company’s typical performance obligations include the following: Performance Obligation When Performance Obligation is Typically Satisfied When Payment is Typically Due How Standalone Selling Price is Typically Estimated Product Revenues Standard purchase orders for delivery of a tangible product Upon shipment (point in time) Within 30 days of delivery Observable transactions Engineering services where the deliverable is considered a product As work is performed (over time) Within 30 days of services being invoiced Estimated using a cost-plus margin approach Service Revenues Engineering, managed services, and consulting services As work is performed (over time) Within 30 days of services being invoiced Estimated using a cost-plus margin approach SaaS Over the course of the SaaS service once the system is available for use (over time) At the beginning of the contract period Estimated using a cost-plus margin approach Extended warranty service Over the course of the extended warranty period (over time) At the beginning of the contract period Estimated using a cost-plus margin approach Disaggregation of Revenue The Company disaggregates revenue from contracts with customers into product revenues and service revenues. Trade Accounts Receivable and Contract Balances We classify our right to consideration in exchange for goods and services as either a receivable or a contract asset. A receivable is a right to consideration that is unconditional (i.e., only the passage of time is required before payment is due). We present such receivables in trade accounts receivable, net, in our unaudited condensed balance sheets at their net estimated realizable value. The Company maintains an allowance for doubtful accounts to provide for the estimated amount of receivables that will not be collected. The Company estimates allowances for expected credit losses on trade accounts receivable and contract assets as required by the Current Expected Credit Loss ("CECL") model, as per Financial Accounting Standards Board ("FASB") Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments - Credit Losses (Topic 326). If warranted, the allowance is increased by the Company’s provision for doubtful accounts, which is charged against income. All recoveries on receivables previously charged off are included in income, while direct charge-offs of receivables are deducted from the allowance. A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented as unbilled accounts receivable on the accompanying unaudited condensed balance sheets. For example, we would record a contract asset if we record revenue on a professional services engagement, but are not entitled to bill until we achieve specified milestones. Our contract assets and refund liabilities are reported in a net position on a contract basis at the end of each reporting period. Refund liabilities are consideration received in advance of the satisfaction of performance obligations. Contract Fulfillment Costs The Company evaluates whether or not we should capitalize the costs of fulfilling a contract. Such costs would be capitalized when they are not within the scope of other standards and: (1) are directly related to a contract; (2) generate or enhance resources that will be used to satisfy performance obligations; and (3) are expected to be recovered. There were approximately $0.4 million and $0.5 million of contract fulfillment costs as of September 30, 2023 and March 31, 2023, respectively, which are presented in the accompanying unaudited condensed balance sheets as prepaid expense. These costs primarily relate to the satisfaction of performance obligations related to the set-up of SaaS platforms. These costs are amortized on a straight-line basis over the estimated useful life of the SaaS platform. Transaction Price Allocated to the Remaining Performance Obligations As of September 30, 2023 and March 31, 2023, the aggregate amount of transaction price allocated to remaining performance obligations was immaterial, primarily as a result of the termination provisions within our contracts, which make the duration of the accounting term of the contract one year or less. Practical Expedients and Exemptions T&M and CPFF contracts are considered variable consideration. However, performance obligations with an underlying fee type of T&M or CPFF qualify for the "Right to Invoice" Practical Expedient under Accounting Standards Codification ("ASC") 606-10-55-18. Under this practical expedient, the Company is not required to estimate such variable consideration upon inception of the contract or reassess the estimate each reporting period. The Company utilizes the practical expedient under ASC 606-10-50-14 of not disclosing information about its remaining performance obligations for contracts with an original expected duration (i.e., contract term, determined based on the analysis of termination provisions described above) of 12 months or less. The Company pays sales commissions on certain sales contracts. These costs are accrued in the same period that the revenues are recorded. Using the practical expedient under ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining a contract as an expense when incurred since the amortization period of the asset that the Company otherwise would have recognized is one year or less. The Company utilizes the practical expedient under ASC 606-10-25-18B to account for shipping and handling as fulfillment costs, and not a promised service (a revenue element). Shipping and handling costs are included as cost of revenues in the period during which the products ship. The Company excludes from the transaction price all sales taxes that are assessed by a governmental authority and that are imposed on and concurrent with a specific revenue-producing transaction and collected from a customer (for example, sales, use, value added, and some excise taxes). This employs the practical expedient under ASC 606-10-32-2A. Sales taxes are presented on a net basis (excluded from revenues) in the accompanying statements of operations. Deferred Revenue Deferred revenue in the accompanying unaudited condensed balance sheets is comprised of refund liabilities related to billings and consideration received in advance of the satisfaction of performance obligations. Concentration of Credit Risk Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents and trade accounts receivable. Cash and cash equivalents consist primarily of demand deposits and money market funds maintained with two financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with high quality financial institutions, and therefore are believed to have minimal credit risk. Accounts at each institution are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. As of September 30, 2023, the Company had approximately $20.1 million of deposits at financial institutions in excess of the FDIC insured limit. Our accounts receivable are primarily derived from billings with customers located throughout North America, as well as in Europe, the Middle East and South America. We generally do not require collateral or other security from our domestic customers. We maintain an allowance for doubtful accounts for potential credit losses, which losses have historically been within management’s expectations. We currently have, and historically have had, a diverse customer base. For the three and six months ended September 30, 2023 and 2022, no individual customer represented greater than 10% of our total revenues. As of September 30, 2023 and March 31, 2023, no individual customer represented greater than 10% of our total accounts receivable. Fair Values of Financial Instruments The accounting guidance provided in ASC 820, Fair Value Measurements for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2—Observable inputs other than quoted prices in active markets for identical assets or liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3—Inputs that are generally unobservable and typically reflect management's estimate of assumptions that market participants would use in pricing the assets or liabilities. The Company applies fair value accounting for all financial instruments on a recurring basis. The Company's financial instruments, which include cash, cash equivalents, accounts receivable and accounts payable are recorded at their carrying amounts, which approximate their fair values due to their short-term nature. All marketable securities are considered to be available-for-sale and recorded at their estimated fair values. In valuing these items, the Company uses inputs and assumptions that market participants would use to determine their fair value, utilizing valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents consist of cash and short-term investments with initial maturities of 90 days or less. As of September 30, 2023 and March 31, 2023, restricted cash was $0.4 million and $0.1 million, respectively, consisting of cash restricted for shares purchased under the Employee Stock Purchase Plan ("ESPP") (see Note 8, Stock-Based Compensation , for further details on the ESPP). Cash, cash equivalents and restricted cash presented in the accompanying unaudited condensed statements of cash flows consisted of the following: September 30, 2023 2022 (In thousands) Cash and cash equivalents $ 20,161 $ 7,991 Restricted cash 449 141 $ 20,610 $ 8,132 Allowance for Doubtful Accounts We record accounts receivable net of the allowance for doubtful accounts. The allowance is established in accordance with the CECL model. We estimate the allowance for doubtful accounts based on the Company's assessment of its ability to collect on customer accounts receivable. The collectability of our accounts receivable is evaluated through review of outstanding invoices and ongoing credit evaluations of our customers' financial condition. In cases where we are aware of circumstances that may impair a specific customer's ability to meet its financial obligations subsequent to the original sale, we will record an allowance against amounts due, and thereby reduce the net recognized accounts receivable to the amount we reasonably believe will be collected. The allowance reflects our best estimate of probable losses associated with the accounts receivable balance. Our assessment is based on historical experience, current information and reasonable and supportable forecasts. Accounts receivables with similar risk characteristics are evaluated collectively and accounts receivables that do not share similar risk characteristics are evaluated individually. Risk characteristics relevant to the Company’s accounts receivable include account balance and aging status. Adjustments to the allowance for doubtful accounts are recorded through bad debt expense, which is included in operating expenses on the accompanying unaudited condensed statements of operations. The Company writes off accounts receivable against the allowance when it determines that the balance is uncollectible and collection of the receivable is no longer being actively pursued. Inventories Inventories consist of raw materials, work-in-process, and finished goods and are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method. Property and Equipment Property and equipment are recorded at cost and are depreciated using the straight-line method over the estimated useful life ranging from three Intangible Assets Intangible assets with determinable economic lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful life of each asset on a straight-line basis. The Company determines the useful lives of identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. When determining useful life, the Company considers the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or other local regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. Capitalized Software Development Cost The Company accounts for costs incurred to develop software for internal use in accordance with ASC 350-40, Intangibles — Internal Use Software (“ASC 350-40”). Under ASC 350-40, the costs incurred during the application development stage, which include costs of software configuration and interface design, coding, installation and testing are required to be capitalized. Costs incurred during the preliminary project along with post-implementation stages of internal use software are expensed as incurred and included in research and development in the unaudited condensed statements of operations. Goodwill Goodwill represents the excess of the aggregate purchase price over the fair value of net identifiable assets acquired in a business combination. Goodwill is not amortized and is tested for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In the valuation of goodwill, management must make assumptions regarding estimated future cash flows to be derived from the Company's business. If these estimates or their related assumptions change in the future, the Company may be required to record impairment for these assets. The Company has the option to first perform a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value. However, the Company may elect to bypass the qualitative assessment and proceed directly to the quantitative impairment tests. The first step of the impairment test involves comparing the fair value of the reporting unit to its net book value, including goodwill. If the net book value exceeds its fair value, the Company would perform the second step of the goodwill impairment test to determine the amount of the impairment loss. We perform an annual quantitative assessment of our goodwill during the fourth fiscal quarter, or more frequently, to determine if any events or circumstances exist, such as an adverse change in business climate or a decline in overall industry demand, that would indicate that it would more likely than not reduce the fair value of a reporting unit below its carrying amount, including goodwill. If events or circumstances do not indicate that the fair value of a reporting unit is below its carrying amount, then goodwill is not considered to be impaired and no further testing is required. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, the amount by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss. We monitor the indicators for goodwill impairment testing between annual tests. During the six months ended September 30, 2023 and 2022, there was no goodwill impairment. Impairment of Long-Lived Assets The Company evaluates its long-lived assets, including property, equipment and intangible assets (other than goodwill) for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We determine whether the carrying value of an asset or asset group is recoverable, based on comparisons to undiscounted expected future cash flows the asset or asset group is expected to generate. If an asset is not recoverable, we record an impairment loss equal to the amount by which the carrying value of the asset exceeds its fair value. During the six months ended September 30, 2023 and 2022, there was no impairment to our long-lived and intangible assets. Income Taxes We utilize the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more-likely-than-not that some or all of the deferred tax assets will not be realized, which increases our income tax expense in the period such determination is made. As such, as of September 30, 2023, we determined it was appropriate to record a full valuation allowance against our deferred tax assets. We will continuously reassess the appropriateness of maintaining a valuation allowance. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are derecognized in the first subsequent financial reporting period in which that threshold is no longer met. Stock-Based Compensation We record stock-based compensation in our unaudited condensed statements of operations as an expense, based on the estimated grant date fair value of our stock-based awards, whereby such fair values are amortized over the requisite service period. Our stock-based awards are currently comprised of common stock options, restricted stock units and performance stock units. The fair value of our common stock option awards is estimated on the grant date using the Black-Scholes-Merton option-pricing formula. The fair value of our performance stock unit awards is estimated on the grant date using a Monte Carlo simulation model. While the use of these models meets established requirements, the estimated fair values generated by the models may not be indicative of the actual fair values of our awards as it does not consider certain factors important to those awards to employees, such as continued employment and periodic vesting requirements, as well as limited transferability. The fair value of our restricted stock units is based on the closing market price of our common stock on the grant date. If there are any modifications or cancellations of the underlying unvested stock-based awards, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense. Warranty We generally provide a one Repair and Maintenance Costs We incur repair and maintenance costs in the normal course of business. Should the repair or maintenance result in a permanent improvement to one of our leased facilities, the cost is capitalized as a leasehold improvement and amortized over its useful life or the remainder of the lease period, whichever is shorter. Non-permanent repair and maintenance costs are charged to expense as incurred. Loss Contingencies We are subject to legal actions that arise in the ordinary course of business. The Company recognizes a liability for a contingency when it is probable that liability has been incurred and when the amount of loss can be reasonably estimated. When a range of |
Supplemental Financial Informat
Supplemental Financial Information | 6 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Supplemental Financial Information | Supplemental Financial Information Inventories The following table presents details of our inventories, net of reserves: September 30, March 31, (In thousands) Raw materials $ 7,771 $ 7,840 Work in process 106 315 Finished goods 2,904 2,686 $ 10,781 $ 10,841 Property and Equipment The following table presents details of our property and equipment, net: September 30, March 31, (In thousands) Equipment $ 6,631 $ 6,359 Leasehold improvements 824 824 Accumulated depreciation (6,130) (5,886) $ 1,325 $ 1,297 Depreciation expense was approximately $0.1 million for each of the three-month periods ended September 30, 2023 and September 30, 2022. Of the total depreciation expense, approximately half was recorded to cost of revenues, and approximately half was recorded to operating expenses for each period. Depreciation expense was approximately $0.3 million for each of the six-month periods ended September 30, 2023 and September 30, 2022. Of the total depreciation expense, approximately $0.1 million was recorded to cost of revenues, and approximately $0.2 million was recorded to operating expenses for each of those periods. Intangible Assets The following table presents details of our net intangible assets: September 30, 2023 March 31, 2023 Gross Accumulated Net Book Gross Accumulated Net Book (In thousands) Technology $ 4,986 $ (3,907) $ 1,079 $ 4,986 $ (3,444) $ 1,542 Customer contracts / relationships 9,550 (5,078) 4,472 9,550 (4,371) 5,179 Trade names and non-compete agreements 782 (770) 12 782 (770) 12 Capitalized software development costs 8,839 (4,434) 4,405 7,489 (4,032) 3,457 Total $ 24,157 $ (14,189) $ 9,968 $ 22,807 $ (12,617) $ 10,190 Amortization expense for intangible assets subject to amortization was approxima tely $0.8 million in total for each of the three-month periods ended September 30, 2023 and September 30, 2022. Of the total amortization expense, approximately $0.1 million was recorded to cost of revenues and approximately $0.7 million was recorded to operating expenses for each period. Amortization expense was approximately $1.6 million in total for each of the six-month periods ended September 30, 2023 and September 30, 2022. Of the total amortization expense, approximately $0.3 million was recorded to cost of revenues, and approximately $1.3 million was recorded to operating expenses for each period. We have one indefinite useful life intangible asset, with de minimis carrying value, which was included in trade names and non-compete agreements. As of September 30, 2023, future estimated amortization expense was as follows: Year Ending March 31, (In thousands) 2024 $ 1,796 2025 3,519 2026 2,295 2027 1,727 2028 619 $ 9,956 The future estimated amortization expense does not include the indefinite useful life intangible asset described above. Warranty Reserve Activity Warranty reserve is recorded as accrued liabilities in the accompanying unaudited condensed balance sheets. The following table presents activity related to the warranty reserve: Six Months Ended 2023 2022 (In thousands) Balance at beginning of fiscal year $ 758 $ 616 Additions charged to cost of sales 245 104 Warranty claims (167) (67) Balance at end of reporting period $ 836 $ 653 Earnings (Loss) Per Share The following table sets forth the computation of basic and diluted net income (loss) per share: Three Months Ended Six Months Ended 2023 2022 2023 2022 (In thousands, except per share amounts) Numerator: Net income (loss) $ 551 $ (7,397) $ 2,676 $ (12,262) Denominator: Weighted average common shares used in basic computation 42,742 42,288 42,654 42,334 Stock options and other dilutive awards 971 — 1,023 — Weighted average common shares used in diluted computation 43,713 42,288 43,677 42,334 Net income (loss) per common share Basic net income (loss) per share $ 0.01 $ (0.17) $ 0.06 $ (0.29) Diluted net income (loss) per share $ 0.01 $ (0.17) $ 0.06 $ (0.29) The following instruments were excluded for purposes of calculating weighted average common share equivalents in the computation of diluted net income (loss) per share as their effect would have been anti-dilutive: Three Months Ended Six Months Ended 2023 2022 2023 2022 (In thousands) Stock options 3,213 5,534 3,287 5,626 Restricted stock units 525 345 402 395 |
Restructuring Activities
Restructuring Activities | 6 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring Activities | Restructuring Activities On May 12, 2022, the Board of Directors of Iteris, Inc. approved restructuring activities to better position the Company for increased profitability and growth. The restructuring activities during the three and six months ended September 30, 2023 were as follows (in thousands): Balance at March 31, 2023 $ 242 Cash payments (197) Balance at June 30, 2023 45 Cash payments (45) Balance at September 30, 2023 $ — |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements We measure fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. As described in more detail in Note 1, Description of Business and Summary of Significant Accounting Policies, fair value measurements are based on a three tier hierarchy that prioritizes the inputs used to measure fair value. We did not have any material financial assets or liabilities measured at fair value on a recurring basis using Level 3 inputs as of September 30, 2023 or March 31, 2023. Our non-financial assets, such as goodwill, intangible assets and property and equipment, are measured at fair value on a nonrecurring basis, generally when there is a transaction involving those assets such as a purchase transaction, a business combination or an adjustment for impairment. No non-financial assets were measured at fair value at September 30, 2023 and March 31, 2023. The following tables present the Company’s financial assets that are recorded at fair value on a recurring basis, segregated among the appropriate levels within the fair value hierarchy: As of September 30, 2023 (In thousands) Amortized Gross Gross Estimated Fair Assets: Level 1: Securities held in deferred compensation plan (1) $ 1,598 $ (483) $ 427 $ 1,542 Total $ 1,598 $ (483) $ 427 $ 1,542 Liabilities: Level 1: Deferred compensation plan liabilities (2) $ 1,613 $ (298) $ 596 $ 1,911 Total $ 1,613 $ (298) $ 596 $ 1,911 As of March 31, 2023 (In thousands) Amortized Gross Gross Estimated Fair Assets: Level 1: Securities held in deferred compensation plan (1) $ 1,426 $ (437) $ 321 $ 1,310 Total $ 1,426 $ (437) $ 321 $ 1,310 Liabilities: Level 1: Deferred compensation plan liabilities (2) $ 1,201 $ (296) $ 563 $ 1,468 Level 3: Contingent consideration (3) 600 — — 600 Transfer out (600) (600) Subtotal — — — — Total $ 1,201 $ (296) $ 563 $ 1,468 (1) Included in prepaid expenses and other current assets on the Company’s balance sheet. (2) Included in accrued payroll and related expenses on the Company’s balance sheet. (3) As of March 31, 2023, the balance of contingent consideration was short-term and included in accrued liabilities in the Company’s balance sheets. As of September 30, 2023, the balance had been paid in full. Unrealized losses related to investments are due to interest rate fluctuations as opposed to credit quality. In addition, we do not intend to sell, and it is not more likely than not that, we would be required to sell, any of our investments before recovery of their cost basis. As a result, there was no other-than-temporary impairment for these investments as of September 30, 2023. |
Income Taxes
Income Taxes | 6 Months Ended |
Sep. 30, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The effective tax rate used for interim periods is the estimated annual effective tax rate, based on the current estimate of full year results, except taxes related to specific events, if any, are recorded in the interim period in which they occur. Income tax benefit was less than $0.1 million, or 6.4% of pretax income, for the three months ended September 30, 2023 as compared to income tax expense of $(0.3) million, or (3.9)% of pretax loss, for the three months ended September 30, 2022. Income tax expense was $(0.1) million, or (2.3)% of pretax income, for the six months ended September 30, 2023 as compared to income tax expense of $(0.1) million, or (1.0)% of pretax loss, for the six months ended September 30, 2022. In assessing the realizability of our deferred tax assets, we review all available positive and negative evidence, including reversal of deferred tax liabilities, potential carrybacks, projected future taxable income, tax planning strategies and recent financial performance. We previously recorded a full valuation allowance against our deferred tax assets due to our cumulative pre-tax losses, and we continue to maintain a valuation allowance against our deferred tax assets. We intend to continue maintaining a full valuation allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Litigation and Other Contingencies As a provider of traffic engineering services, hardware products, software and other various solutions for the traffic industry, the Company is, and may in the future from time to time, be involved in disputes, proceedings, or litigation relating to claims arising out of its operations in the normal course of business, such as intellectual property infringement and contractual matters. While the Company cannot accurately predict the outcome of any such disputes, proceedings, or litigation, including |
Right-of-Use Assets and Lease L
Right-of-Use Assets and Lease Liabilities | 6 Months Ended |
Sep. 30, 2023 | |
Lessee Disclosure [Abstract] | |
Right-of-Use Assets and Lease Liabilities | Right-of-Use Assets and Lease Liabilities We have various operating leases for our offices, office equipment and vehicles in the U.S. These leases expire at various times through 2029. Certain lease agreements contain renewal options from 1 year to 5 years, rent abatement, and escalation clauses that are factored into our determination of lease payments when appropriate. The table below presents lease-related assets and liabilities recorded on the unaudited condensed balance sheet as follows: Classification September 30, 2023 March 31, 2023 (In thousands) Assets Operating lease right-of-use-assets Right-of-use assets $ 7,509 $ 8,345 Total operating lease right-of-use-assets $ 7,509 $ 8,345 Liabilities Operating lease liabilities (short-term) Accrued liabilities $ 2,319 $ 2,339 Operating lease liabilities (long-term) Lease liabilities 6,560 7,641 Total lease liabilities $ 8,879 $ 9,980 Lease Costs We recorded approximately $0.6 million and $1.2 million of lease costs in our unaudited condensed statements of operations for the three and six months ended September 30, 2023, respectively, as compared to approximately $0.6 million and $1.3 million for the three and six months ended September 30, 2022, respectively. The Company currently has no variable lease costs. Supplemental Information Information related to the Company right-of-use assets and related operating lease liabilities were as follows: Six Months Ended 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities (in thousands) $ 1,346 $ 706 Weighted average remaining lease term (in years) 3.5 4.3 Weighted average discount rate 4.7 % 4.8 % Maturities of Lease Liabilities Maturities of lease liabilities as of September 30, 2023 were as follows: Fiscal Year Ending March 31, Operating Leases (In thousands) 2024 $ 1,348 2025 2,483 2026 2,178 2027 2,207 2028 1,315 Thereafter 204 Total lease payments 9,735 Less imputed interest (856) Present value of future lease payments 8,879 Less current obligations under leases (2,319) Long-term lease obligations $ 6,560 |
Stock-Based Compensation
Stock-Based Compensation | 6 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation We currently maintain two stock incentive plans, the 2007 Omnibus Incentive Plan and the 2016 Omnibus Incentive Plan (the “2016 Plan”). Of these plans, we may only grant future awards from the 2016 Plan. The 2016 Plan allows for the issuance of stock options, stock appreciation rights, restricted stock, time-restricted stock units (“RSUs"), performance-based restricted stock units ("PSUs”), cash incentive awards and other stock-based awards. At September 30, 2023, there were approximately 1.7 million shares of common stock available for grant or issuance under the 2016 Plan. Total stock options vested and expected to vest were approximately 5.9 million as of September 30, 2023. Stock Options A summary of activity with respect to our stock options for the six months ended September 30, 2023 is as follows: Shares Weighted- (In thousands) Options outstanding at March 31, 2023 6,287 $ 4.11 Granted 266 4.06 Exercised (104) 3.22 Forfeited (403) 4.04 Expired (195) 4.85 Options outstanding at September 30, 2023 5,851 4.10 Restricted Stock Units A summary of activity with respect to our RSUs, which entitle the holder to receive one share of our common stock for each RSU upon vesting, for the six months ended September 30, 2023 is as follows: Shares Weighted-Average (In thousands) RSUs outstanding at March 31, 2023 497 $ 4.12 Granted 274 4.08 Vested and released (80) 3.39 Forfeited (45) 4.12 RSUs outstanding at September 30, 2023 646 4.19 Performance Stock Units The Board has approved PSUs to our executive officers and certain Vice Presidents. Between 0% and 160% of the PSUs will be eligible to vest based on annual performance during the three-year performance period relative to the revenues per share and cash flow from operations objectives to be established by the Compensation Committee at the beginning of each year. In addition, the final PSU vesting based on the revenues per share and cash flow from operations performance will be subject to a modifier between .75x-1.25x based on the Company's total shareholder return relative to the Russell 2000 for the span of the full three-year performance period, with a maximum achievement percentage of 200% of the "target" number of PSUs. The PSUs are amortized over a derived service period of three years. The value and the derived service period of the PSUs were estimated using the Monte-Carlo simulation model. The following table summarizes the details of the performance stock units: Shares Weighted-Average (In thousands) PSUs outstanding at March 31, 2023 83 $ 4.45 Granted 223 2.60 Vested and released (43) 4.98 Forfeited (59) 3.61 PSUs outstanding at September 30, 2023 204 2.56 Stock-Based Compensation Expense The following table presents stock-based compensation expense that is included in each line item on our unaudited condensed statements of operations: Three Months Ended Six Months Ended 2023 2022 2023 2022 (In thousands) Cost of revenues $ 58 $ 78 $ 143 $ 142 General and administrative 513 347 715 965 Sales and marketing 157 116 291 194 Research and development 144 155 247 243 Total stock-based compensation $ 872 $ 696 $ 1,396 $ 1,544 As of September 30, 2023, there was approximately $3.2 million, $1.6 million and $0.3 million of unrecognized compensation expense related to unvested stock options, RSUs and PSUs, respectively. This expense is currently expected to be recognized over a weighted average period of approximately 2.5 years for stock options, 1.7 years for RSUs and 2.1 years for PSUs. If there are any modifications or cancellations of the underlying unvested awards, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense. Future stock-based compensation expense and unearned stock-based compensation will increase to the extent that we grant additional stock options, RSUs or other stock-based awards. Other Stock-Based Compensation Plans We currently maintain an Employee Stock Purchase Plan (“ESPP”) that allows employees to have a percentage of their base compensation withheld to purchase the Company’s common stock at 95% of the lower of the fair market at the beginning of the offering period and on the last trading day of the offering period. There are two offering periods during a calendar year, which consist of the six months beginning each January 1 and July 1. Employees may contribute 1-15% of their eligible gross pay up to a $0.03 million annual stock value limit. In July 2023, 92,097 shares related to the first offering period of Fiscal 2024 were purchased. In July 2022, 84,426 shares related to the first offering period of Fiscal 2023 were purchased. Deferred Compensation Plan Effective October 1, 2020, the Company adopted the Iteris, Inc. Deferred Compensation Plan (the "DC Plan"). The DC Plan consists of two plans, one that is intended to be an unfunded arrangement for eligible employees who are part of a select group of management or highly compensated employees of the Company within the meaning of Sections 201(2), 301(a)(3) and 401(a)(1) of ERISA, and one for the benefit of non-employee members of our board of directors. Key employees, including our executive officers, and our non-employee directors who are notified regarding their eligibility to participate and delivered the DC Plan enrollment materials are eligible to participate in the DC Plan. Under the DC Plan, we provide participants with the opportunity to make annual elections to defer a percentage of their eligible cash compensation and equity awards. A participant is always 100% vested in his or her own elective cash deferrals and any earnings thereon. Elective deferrals of equity awards are credited to a bookkeeping account established in the name of the participant with respect to an equivalent number of shares of our common stock, and such credited shares are subject to the same vesting conditions as are applicable to the equity award subject to the election. The Company established a rabbi trust to finance our obligations under the DC Plan with corporate-owned life insurance policies on participants, and the assets held within this trust are subject to the claims of the Company's creditors. The assets and liabilities are recorded at their fair value, which represents their respective amortized cost values plus any unrealized gains or losses. Refer to Note 4, Fair Value Measurements , for further detail on the DC Plan. |
Stock Repurchase Program
Stock Repurchase Program | 6 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Stock Repurchase Program | Stock Repurchase Program On August 9, 2012, the Board approved a stock repurchase program pursuant to which we could acquire up to $3.0 million of our outstanding common stock for an unspecified length of time. Under the program, we could repurchase shares from time to time in the open market and privately negotiated transactions and block trades, and could also repurchase shares pursuant to a 10b5-1 trading plan during our closed trading windows. There was no guarantee as to the exact number of shares that would be repurchased. We reserved the right to modify or terminate the repurchase program at any time without prior notice. On November 6, 2014, the Board approved a $3.0 million increase to the Company’s 2012 stock repurchase program, pursuant to which the Company could continue to acquire shares of its outstanding common stock from time to time for an unspecified length of time. From the inception of the 2012 stock repurchase program on through its termination on May 12, 2022, we repurchased approximately 2,458,000 shares of our common stock for an aggregate price of approximately $4.3 million, at an average price per share of $1.73. As of September 30, 2023, these repurchased shares had been retired and resumed their status as authorized and unissued shares of our common stock. On May 12, 2022, the Board of Directors approved a new plan for the Company to acquire up to $10.0 million of its outstanding common stock for an unspecified length of time. Under the 2022 stock repurchase program, we may repurchase shares from time to time in the open market and privately negotiated transactions and block trades and may also repurchase shares pursuant to a 10b5-1 trading plan during our closed trading windows. There is no guarantee as to the exact number of shares that will be repurchased. We may modify or terminate the repurchase program at any time without prior notice. During the quarter ended September 30, 2023, there were no repurchases. As of September 30, 2023 approximately $9.1 million remained available for the repurchase of our common stock under our current program. |
Business Segments
Business Segments | 6 Months Ended |
Sep. 30, 2023 | |
Segment Reporting [Abstract] | |
Business Segments | Business SegmentsThe Company's Chief Operating Decision Maker ("CODM"), who is our Chief Executive Officer, reviews the Company's results on a consolidated basis and our financial results are presented under a single reporting segment in order to provide the most accurate representation of the Company's performance. |
Long-Term Debt
Long-Term Debt | 6 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Long-Term Debt | Long-Term Debt On January 25, 2022, Iteris, Inc., entered into a Credit Agreement (the “Credit Agreement”) with Capital One, National Association, as agent. The Credit Agreement provided for a $20 million revolving credit facility with a maturity date of January 24, 2026. In addition, the Company had the ability from time to time to increase the revolving commitments up to an additional aggregate amount not to exceed $40 million, subject to receipt of lender commitments and certain conditions precedent. The Credit Agreement that evidenced the facility contained customary representations, warranties, covenants, and events of default. The Credit Agreement was collateralized by substantially all of our property and assets, including intellectual property. The Credit Agreement also contained certain restrictions and covenants that required the Company to maintain, on an ongoing basis, (i) a leverage ratio of no greater than 3.00 to 1.00 and (ii) a fixed charge coverage ratio of not less than 1.25 to 1.00. The leverage ratio also determined the applicable interest rate under the Credit Agreement. Borrowings under the revolving credit facility accrued interest at a rate equal to either Secured Overnight Financing Rate ("SOFR") or a specified base rate, at the Company’s option, plus an applicable margin. The applicable margins ranged from 2.00% to 2.80% per annum for SOFR loans and 1.00% to 1.80% per annum for base rate loans. The revolving credit facility was subject to a commitment fee payable on the unused revolving credit facility commitments ranging from 0.25% to 0.35%, that was dependent on the Company’s leverage ratio. On September 12, 2022, the Company voluntarily terminated the Credit Agreement and expensed the remaining capitalized deferred financing costs. The Company had not borrowed against the Credit Agreement since its inception, but the Company continued to incur customary fees thereunder prior to this termination. In connection with the termination of the Credit Agreement, all liens securing such obligations and guarantees of such obligations were released. Amortization of the deferred financing costs and commitment fees on the unused revolving credit facility commitments of $0.3 million are included in interest income (expense), net on the unaudited condensed statement of operations. As of September 30, 2023, no amounts of capitalized deferred financing costs remained. |
Description of Business and S_2
Description of Business and Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation Our unaudited condensed financial statements have been prepared in accordance with the rules of the SEC for interim reporting, which permit certain footnotes or other financial information that are normally required by generally accepted accounting principles in the U.S. (“GAAP”) to be condensed or omitted. These unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and related notes included in its Annual Report on Form 10-K for Fiscal 2023, filed with the SEC on June 29, 2023. All intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the three and six months ended September 30, 2023 are not necessarily indicative of the results to be expected for fiscal year ended March 31, 2024 ("Fiscal 2024") or any other future periods. |
Use of Estimates | Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires our management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and reported amounts of revenues and expenses during the reporting period. Significant estimates made in the preparation of the financial statements include, but are not limited to, recoverability of long-lived and intangible assets; estimates of future cash flows used to assess the recoverability of the impairment of goodwill; collectability of accounts receivable; projections of taxable income used to assess realizability of deferred tax assets; warranty reserves; costs to complete long-term contracts; indirect cost rates used in cost plus contracts; fair value of stock option awards and equity instruments; capitalization and estimated useful life of the Company's internal-use software development costs. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. However, future events are subject to change and best estimates and judgments may require further adjustments, therefore, actual results could differ materially from those estimates. Management periodically evaluates such estimates and they are adjusted prospectively based upon such evaluation. |
Revenue Recognition | Revenue Recognition The Company recognizes revenues when control of the promised goods or services are transferred to our customers, in an amount that reflects the consideration that we expect to be entitled to in exchange for those goods or services. We generate all of our revenue from contracts with customers, ranging from purchase orders to multi-year agreements. Product revenue related contracts with customers begin when we acknowledge a purchase order for a specific customer order of product to be delivered in the near term. These purchase orders are generally short-term in nature. Product revenue is recognized at a point in time upon shipment or upon customer receipt of the product, depending on shipping terms. The Company determined that this method best represents the transfer of goods as transfer of control typically occurs upon shipment or upon customer receipt of the product. Service revenues consist of revenues derived from maintenance support contracts and subscription agreements for the use of the Company’s service platforms and Application Programming Interfaces ("API's"). We generate this revenue from fees for maintenance and support, monthly active user fees, SaaS fees, and hosting and storage fees. In most cases, the subscription or transaction arrangement is a single performance obligation comprised of a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service). The Company applies a time-based measure of progress to the total transaction price, which results in ratable recognition over the term of the contract. The Company determined that this method best represents the transfer of services as the customer obtains equal benefit from the service throughout the service period. Service revenues are also derived from long-term engineering and consulting service contracts, primarily with governmental agencies. These contracts generally include performance obligations in which control is transferred over time. We recognize revenue on fixed fee contracts over time, using the proportion of actual costs incurred to the total costs expected to complete the contract performance obligation. The Company determined that this method best represents the transfer of services as the proportion closely depicts the efforts or inputs completed towards the satisfaction of a fixed fee contract performance obligation. Time & Materials (“T&M”) and Cost Plus Fixed Fee (“CPFF”) contracts are considered to involve variable consideration. However, contractual performance obligations with these fee types qualify for the “Right to Invoice” practical expedient. Under this practical expedient, the Company is allowed to recognize revenue over time, in the amount to which the Company has a right to invoice. In addition, the Company is not required to estimate such variable consideration upon inception of the contract and reassess the estimate each reporting period. The Company determined that this method best represents the transfer of services as, upon billing, the Company has a right to consideration from a customer in an amount that directly corresponds with the value to the customer of the Company’s performance completed to date. The Company accounts for individual goods and services separately if they are distinct performance obligations, which often requires significant judgment based upon knowledge of the products and/or services, the solution provided and the structure of the sales contract. In SaaS agreements, we provide a service to the customer that combines the software functionality, maintenance and hosting into a single performance obligation. In product-related contracts, a purchase order may cover different products, each constituting a separate performance obligation. We generally estimate variable consideration at the most likely amount to which we expect to be entitled and in certain cases based on the expected value, which requires judgment. We include estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Our estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of our anticipated performance and all information (historical, current and forecasted) that is reasonably available to us. We review and update these estimates on a quarterly basis. The Company’s typical performance obligations include the following: Performance Obligation When Performance Obligation is Typically Satisfied When Payment is Typically Due How Standalone Selling Price is Typically Estimated Product Revenues Standard purchase orders for delivery of a tangible product Upon shipment (point in time) Within 30 days of delivery Observable transactions Engineering services where the deliverable is considered a product As work is performed (over time) Within 30 days of services being invoiced Estimated using a cost-plus margin approach Service Revenues Engineering, managed services, and consulting services As work is performed (over time) Within 30 days of services being invoiced Estimated using a cost-plus margin approach SaaS Over the course of the SaaS service once the system is available for use (over time) At the beginning of the contract period Estimated using a cost-plus margin approach Extended warranty service Over the course of the extended warranty period (over time) At the beginning of the contract period Estimated using a cost-plus margin approach Disaggregation of Revenue The Company disaggregates revenue from contracts with customers into product revenues and service revenues. Trade Accounts Receivable and Contract Balances We classify our right to consideration in exchange for goods and services as either a receivable or a contract asset. A receivable is a right to consideration that is unconditional (i.e., only the passage of time is required before payment is due). We present such receivables in trade accounts receivable, net, in our unaudited condensed balance sheets at their net estimated realizable value. The Company maintains an allowance for doubtful accounts to provide for the estimated amount of receivables that will not be collected. The Company estimates allowances for expected credit losses on trade accounts receivable and contract assets as required by the Current Expected Credit Loss ("CECL") model, as per Financial Accounting Standards Board ("FASB") Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments - Credit Losses (Topic 326). If warranted, the allowance is increased by the Company’s provision for doubtful accounts, which is charged against income. All recoveries on receivables previously charged off are included in income, while direct charge-offs of receivables are deducted from the allowance. A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented as unbilled accounts receivable on the accompanying unaudited condensed balance sheets. For example, we would record a contract asset if we record revenue on a professional services engagement, but are not entitled to bill until we achieve specified milestones. Our contract assets and refund liabilities are reported in a net position on a contract basis at the end of each reporting period. Refund liabilities are consideration received in advance of the satisfaction of performance obligations. Contract Fulfillment Costs The Company evaluates whether or not we should capitalize the costs of fulfilling a contract. Such costs would be capitalized when they are not within the scope of other standards and: (1) are directly related to a contract; (2) generate or enhance resources that will be used to satisfy performance obligations; and (3) are expected to be recovered. There were approximately $0.4 million and $0.5 million of contract fulfillment costs as of September 30, 2023 and March 31, 2023, respectively, which are presented in the accompanying unaudited condensed balance sheets as prepaid expense. These costs primarily relate to the satisfaction of performance obligations related to the set-up of SaaS platforms. These costs are amortized on a straight-line basis over the estimated useful life of the SaaS platform. Transaction Price Allocated to the Remaining Performance Obligations As of September 30, 2023 and March 31, 2023, the aggregate amount of transaction price allocated to remaining performance obligations was immaterial, primarily as a result of the termination provisions within our contracts, which make the duration of the accounting term of the contract one year or less. Practical Expedients and Exemptions T&M and CPFF contracts are considered variable consideration. However, performance obligations with an underlying fee type of T&M or CPFF qualify for the "Right to Invoice" Practical Expedient under Accounting Standards Codification ("ASC") 606-10-55-18. Under this practical expedient, the Company is not required to estimate such variable consideration upon inception of the contract or reassess the estimate each reporting period. The Company utilizes the practical expedient under ASC 606-10-50-14 of not disclosing information about its remaining performance obligations for contracts with an original expected duration (i.e., contract term, determined based on the analysis of termination provisions described above) of 12 months or less. The Company pays sales commissions on certain sales contracts. These costs are accrued in the same period that the revenues are recorded. Using the practical expedient under ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining a contract as an expense when incurred since the amortization period of the asset that the Company otherwise would have recognized is one year or less. The Company utilizes the practical expedient under ASC 606-10-25-18B to account for shipping and handling as fulfillment costs, and not a promised service (a revenue element). Shipping and handling costs are included as cost of revenues in the period during which the products ship. The Company excludes from the transaction price all sales taxes that are assessed by a governmental authority and that are imposed on and concurrent with a specific revenue-producing transaction and collected from a customer (for example, sales, use, value added, and some excise taxes). This employs the practical expedient under ASC 606-10-32-2A. Sales taxes are presented on a net basis (excluded from revenues) in the accompanying statements of operations. |
Deferred Revenue | Deferred Revenue Deferred revenue in the accompanying unaudited condensed balance sheets is comprised of refund liabilities related to billings and consideration received in advance of the satisfaction of performance obligations. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents and trade accounts receivable. Cash and cash equivalents consist primarily of demand deposits and money market funds maintained with two financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with high quality financial institutions, and therefore are believed to have minimal credit risk. Accounts at each institution are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. As of September 30, 2023, the Company had approximately $20.1 million of deposits at financial institutions in excess of the FDIC insured limit. Our accounts receivable are primarily derived from billings with customers located throughout North America, as well as in Europe, the Middle East and South America. We generally do not require collateral or other security from our domestic customers. We maintain an allowance for doubtful accounts for potential credit losses, which losses have historically been within management’s expectations. We currently have, and historically have had, a diverse customer base. For the three and six months ended September 30, 2023 and 2022, no individual customer represented greater than 10% of our total revenues. As of September 30, 2023 and March 31, 2023, no individual customer represented greater than 10% of our total accounts receivable. |
Fair Values of Financial Instruments | Fair Values of Financial Instruments The accounting guidance provided in ASC 820, Fair Value Measurements for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2—Observable inputs other than quoted prices in active markets for identical assets or liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3—Inputs that are generally unobservable and typically reflect management's estimate of assumptions that market participants would use in pricing the assets or liabilities. The Company applies fair value accounting for all financial instruments on a recurring basis. The Company's financial instruments, which include cash, cash equivalents, accounts receivable and accounts payable are recorded at their carrying amounts, which approximate their fair values due to their short-term nature. All marketable securities are considered to be available-for-sale and recorded at their estimated fair values. In valuing these items, the Company uses inputs and assumptions that market participants would use to determine their fair value, utilizing valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. |
Cash, Cash Equivalents and Restricted Cash | Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents consist of cash and short-term investments with initial maturities of 90 days or less. |
Allowance for Doubtful Accounts | Allowance for Doubtful Accounts We record accounts receivable net of the allowance for doubtful accounts. The allowance is established in accordance with the CECL model. We estimate the allowance for doubtful accounts based on the Company's assessment of its ability to collect on customer accounts receivable. The collectability of our accounts receivable is evaluated through review of outstanding invoices and ongoing credit evaluations of our customers' financial condition. In cases where we are aware of circumstances that may impair a specific customer's ability to meet its financial obligations subsequent to the original sale, we will record an allowance against amounts due, and thereby reduce the net recognized accounts receivable to the amount we reasonably believe will be collected. The allowance reflects our best estimate of probable losses associated with the accounts receivable balance. Our assessment is based on historical experience, current information and reasonable and supportable forecasts. Accounts receivables with similar risk characteristics are evaluated collectively and accounts receivables that do not share similar risk characteristics are evaluated individually. Risk characteristics relevant to the Company’s accounts receivable include account balance and aging status. Adjustments to the allowance for doubtful accounts are recorded through bad debt expense, which is included in operating expenses on the accompanying unaudited condensed statements of operations. The Company writes off accounts receivable against the allowance when it determines that the balance is uncollectible and collection of the receivable is no longer being actively pursued. |
Inventories | Inventories consist of raw materials, work-in-process, and finished goods and are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method. |
Property and Equipment | Property and Equipment Property and equipment are recorded at cost and are depreciated using the straight-line method over the estimated useful life ranging from three |
Intangible Assets | Intangible AssetsIntangible assets with determinable economic lives are carried at cost, less accumulated amortization. Amortization is computed over the estimated useful life of each asset on a straight-line basis. The Company determines the useful lives of identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. When determining useful life, the Company considers the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or other local regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. |
Capitalized Software Development Cost | Capitalized Software Development Cost The Company accounts for costs incurred to develop software for internal use in accordance with ASC 350-40, Intangibles — Internal Use Software (“ASC 350-40”). Under ASC 350-40, the costs incurred during the application development stage, which include costs of software configuration and interface design, coding, installation and testing are required to be capitalized. Costs incurred during the preliminary project along with post-implementation stages of internal use software are expensed as incurred and included in research and development in the unaudited condensed statements of operations. |
Goodwill and Impairment of Long-Lived Assets | Goodwill Goodwill represents the excess of the aggregate purchase price over the fair value of net identifiable assets acquired in a business combination. Goodwill is not amortized and is tested for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In the valuation of goodwill, management must make assumptions regarding estimated future cash flows to be derived from the Company's business. If these estimates or their related assumptions change in the future, the Company may be required to record impairment for these assets. The Company has the option to first perform a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value. However, the Company may elect to bypass the qualitative assessment and proceed directly to the quantitative impairment tests. The first step of the impairment test involves comparing the fair value of the reporting unit to its net book value, including goodwill. If the net book value exceeds its fair value, the Company would perform the second step of the goodwill impairment test to determine the amount of the impairment loss. We perform an annual quantitative assessment of our goodwill during the fourth fiscal quarter, or more frequently, to determine if any events or circumstances exist, such as an adverse change in business climate or a decline in overall industry demand, that would indicate that it would more likely than not reduce the fair value of a reporting unit below its carrying amount, including goodwill. If events or circumstances do not indicate that the fair value of a reporting unit is below its carrying amount, then goodwill is not considered to be impaired and no further testing is required. If the carrying amount of a reporting unit exceeds the reporting unit's fair value, the amount by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss. We monitor the indicators for goodwill impairment testing between annual tests. During the six months ended September 30, 2023 and 2022, there was no goodwill impairment. Impairment of Long-Lived Assets The Company evaluates its long-lived assets, including property, equipment and intangible assets (other than goodwill) for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We determine whether the carrying value of an asset or asset group is recoverable, based on comparisons to undiscounted expected future cash flows the asset or asset group is expected to generate. If an asset is not recoverable, we record an impairment loss equal to the amount by which the carrying value of the asset exceeds its fair value. During the six months ended September 30, 2023 and 2022, there was no impairment to our long-lived and intangible assets. |
Income Taxes | Income Taxes We utilize the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more-likely-than-not that some or all of the deferred tax assets will not be realized, which increases our income tax expense in the period such determination is made. As such, as of September 30, 2023, we determined it was appropriate to record a full valuation allowance against our deferred tax assets. We will continuously reassess the appropriateness of maintaining a valuation allowance. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are derecognized in the first subsequent financial reporting period in which that threshold is no longer met. |
Stock-Based Compensation | Stock-Based CompensationWe record stock-based compensation in our unaudited condensed statements of operations as an expense, based on the estimated grant date fair value of our stock-based awards, whereby such fair values are amortized over the requisite service period. Our stock-based awards are currently comprised of common stock options, restricted stock units and performance stock units. The fair value of our common stock option awards is estimated on the grant date using the Black-Scholes-Merton option-pricing formula. The fair value of our performance stock unit awards is estimated on the grant date using a Monte Carlo simulation model. While the use of these models meets established requirements, the estimated fair values generated by the models may not be indicative of the actual fair values of our awards as it does not consider certain factors important to those awards to employees, such as continued employment and periodic vesting requirements, as well as limited transferability. The fair value of our restricted stock units is based on the closing market price of our common stock on the grant date. If there are any modifications or cancellations of the underlying unvested stock-based awards, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense. |
Warranty | Warranty We generally provide a one |
Repair and Maintenance Costs | Repair and Maintenance Costs We incur repair and maintenance costs in the normal course of business. Should the repair or maintenance result in a permanent improvement to one of our leased facilities, the cost is capitalized as a leasehold improvement and amortized over its useful life or the remainder of the lease period, whichever is shorter. Non-permanent repair and maintenance costs are charged to expense as incurred. |
Loss Contingencies | Loss Contingencies We are subject to legal actions that arise in the ordinary course of business. The Company recognizes a liability for a contingency when it is probable that liability has been incurred and when the amount of loss can be reasonably estimated. When a range of probable loss can be estimated, the Company accrues the most likely amount of such loss at no less than the minimum of the range. The Company expenses legal defense costs as incurred. |
Comprehensive Income (Loss) | Comprehensive Income (Loss) Net income (loss) was the same as comprehensive income (loss) for the three and six months ended September 30, 2023 and September 30, 2022. |
Recent Accounting Pronouncements | Recent Accounting PronouncementsIn June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments. This standard update requires that certain financial assets be measured at amortized cost net of an allowance for estimated credit losses such that the net receivable represents the present value of expected cash collection. In addition, this standard update requires that certain financial assets be measured at amortized cost reflecting an allowance for estimated credit losses expected to occur over the life of the assets. The estimate of credit losses must be based on all relevant information including historical information, current conditions and reasonable and supportable forecasts that affect the collectability of the amounts. In November 2019, the FASB issued ASU 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates, which deferred the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except SEC reporting companies that are not smaller reporting companies. As a smaller reporting company, ASU 2016-13 is now effective for our Fiscal 2024. The Company adopted the standard with an immaterial expected credit loss and no adjustment to the opening balance. |
Description of Business and S_3
Description of Business and Summary of Significant Accounting Policies (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Typical Performance Obligations | The Company’s typical performance obligations include the following: Performance Obligation When Performance Obligation is Typically Satisfied When Payment is Typically Due How Standalone Selling Price is Typically Estimated Product Revenues Standard purchase orders for delivery of a tangible product Upon shipment (point in time) Within 30 days of delivery Observable transactions Engineering services where the deliverable is considered a product As work is performed (over time) Within 30 days of services being invoiced Estimated using a cost-plus margin approach Service Revenues Engineering, managed services, and consulting services As work is performed (over time) Within 30 days of services being invoiced Estimated using a cost-plus margin approach SaaS Over the course of the SaaS service once the system is available for use (over time) At the beginning of the contract period Estimated using a cost-plus margin approach Extended warranty service Over the course of the extended warranty period (over time) At the beginning of the contract period Estimated using a cost-plus margin approach |
Schedule of Cash, Cash Equivalents and Restricted Cash | Cash, cash equivalents and restricted cash presented in the accompanying unaudited condensed statements of cash flows consisted of the following: September 30, 2023 2022 (In thousands) Cash and cash equivalents $ 20,161 $ 7,991 Restricted cash 449 141 $ 20,610 $ 8,132 |
Supplemental Financial Inform_2
Supplemental Financial Information (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Inventories | The following table presents details of our inventories, net of reserves: September 30, March 31, (In thousands) Raw materials $ 7,771 $ 7,840 Work in process 106 315 Finished goods 2,904 2,686 $ 10,781 $ 10,841 |
Schedule of Property And Equipment, Net | The following table presents details of our property and equipment, net: September 30, March 31, (In thousands) Equipment $ 6,631 $ 6,359 Leasehold improvements 824 824 Accumulated depreciation (6,130) (5,886) $ 1,325 $ 1,297 |
Schedule of Net Intangible Assets | The following table presents details of our net intangible assets: September 30, 2023 March 31, 2023 Gross Accumulated Net Book Gross Accumulated Net Book (In thousands) Technology $ 4,986 $ (3,907) $ 1,079 $ 4,986 $ (3,444) $ 1,542 Customer contracts / relationships 9,550 (5,078) 4,472 9,550 (4,371) 5,179 Trade names and non-compete agreements 782 (770) 12 782 (770) 12 Capitalized software development costs 8,839 (4,434) 4,405 7,489 (4,032) 3,457 Total $ 24,157 $ (14,189) $ 9,968 $ 22,807 $ (12,617) $ 10,190 |
Schedule of Future Estimated Amortization Expense | As of September 30, 2023, future estimated amortization expense was as follows: Year Ending March 31, (In thousands) 2024 $ 1,796 2025 3,519 2026 2,295 2027 1,727 2028 619 $ 9,956 |
Schedule of Warranty Reserve Activity | The following table presents activity related to the warranty reserve: Six Months Ended 2023 2022 (In thousands) Balance at beginning of fiscal year $ 758 $ 616 Additions charged to cost of sales 245 104 Warranty claims (167) (67) Balance at end of reporting period $ 836 $ 653 |
Schedule of Computation of Basic and Diluted Net Loss Per Share | The following table sets forth the computation of basic and diluted net income (loss) per share: Three Months Ended Six Months Ended 2023 2022 2023 2022 (In thousands, except per share amounts) Numerator: Net income (loss) $ 551 $ (7,397) $ 2,676 $ (12,262) Denominator: Weighted average common shares used in basic computation 42,742 42,288 42,654 42,334 Stock options and other dilutive awards 971 — 1,023 — Weighted average common shares used in diluted computation 43,713 42,288 43,677 42,334 Net income (loss) per common share Basic net income (loss) per share $ 0.01 $ (0.17) $ 0.06 $ (0.29) Diluted net income (loss) per share $ 0.01 $ (0.17) $ 0.06 $ (0.29) |
Schedule of Instruments Excluded in the Computation of Diluted Net Loss Per Share | The following instruments were excluded for purposes of calculating weighted average common share equivalents in the computation of diluted net income (loss) per share as their effect would have been anti-dilutive: Three Months Ended Six Months Ended 2023 2022 2023 2022 (In thousands) Stock options 3,213 5,534 3,287 5,626 Restricted stock units 525 345 402 395 |
Restructuring Activities (Table
Restructuring Activities (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Restructuring Activities | The restructuring activities during the three and six months ended September 30, 2023 were as follows (in thousands): Balance at March 31, 2023 $ 242 Cash payments (197) Balance at June 30, 2023 45 Cash payments (45) Balance at September 30, 2023 $ — |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Financial Assets that are Recorded at Fair Value on a Recurring Basis | The following tables present the Company’s financial assets that are recorded at fair value on a recurring basis, segregated among the appropriate levels within the fair value hierarchy: As of September 30, 2023 (In thousands) Amortized Gross Gross Estimated Fair Assets: Level 1: Securities held in deferred compensation plan (1) $ 1,598 $ (483) $ 427 $ 1,542 Total $ 1,598 $ (483) $ 427 $ 1,542 Liabilities: Level 1: Deferred compensation plan liabilities (2) $ 1,613 $ (298) $ 596 $ 1,911 Total $ 1,613 $ (298) $ 596 $ 1,911 As of March 31, 2023 (In thousands) Amortized Gross Gross Estimated Fair Assets: Level 1: Securities held in deferred compensation plan (1) $ 1,426 $ (437) $ 321 $ 1,310 Total $ 1,426 $ (437) $ 321 $ 1,310 Liabilities: Level 1: Deferred compensation plan liabilities (2) $ 1,201 $ (296) $ 563 $ 1,468 Level 3: Contingent consideration (3) 600 — — 600 Transfer out (600) (600) Subtotal — — — — Total $ 1,201 $ (296) $ 563 $ 1,468 (1) Included in prepaid expenses and other current assets on the Company’s balance sheet. (2) Included in accrued payroll and related expenses on the Company’s balance sheet. (3) As of March 31, 2023, the balance of contingent consideration was short-term and included in accrued liabilities in the Company’s balance sheets. As of September 30, 2023, the balance had been paid in full. |
Right-of-Use Assets and Lease_2
Right-of-Use Assets and Lease Liabilities (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Lessee Disclosure [Abstract] | |
Schedule of Lease-related Assets and Liabilities Recorded on the Unaudited Condensed Consolidated Balance Sheet | The table below presents lease-related assets and liabilities recorded on the unaudited condensed balance sheet as follows: Classification September 30, 2023 March 31, 2023 (In thousands) Assets Operating lease right-of-use-assets Right-of-use assets $ 7,509 $ 8,345 Total operating lease right-of-use-assets $ 7,509 $ 8,345 Liabilities Operating lease liabilities (short-term) Accrued liabilities $ 2,319 $ 2,339 Operating lease liabilities (long-term) Lease liabilities 6,560 7,641 Total lease liabilities $ 8,879 $ 9,980 |
Schedule of Supplemental Information Related to Operating Leases | Information related to the Company right-of-use assets and related operating lease liabilities were as follows: Six Months Ended 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities (in thousands) $ 1,346 $ 706 Weighted average remaining lease term (in years) 3.5 4.3 Weighted average discount rate 4.7 % 4.8 % |
Schedule of Undiscounted Cash Flows | Maturities of lease liabilities as of September 30, 2023 were as follows: Fiscal Year Ending March 31, Operating Leases (In thousands) 2024 $ 1,348 2025 2,483 2026 2,178 2027 2,207 2028 1,315 Thereafter 204 Total lease payments 9,735 Less imputed interest (856) Present value of future lease payments 8,879 Less current obligations under leases (2,319) Long-term lease obligations $ 6,560 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Activity With Respect to Stock Options | A summary of activity with respect to our stock options for the six months ended September 30, 2023 is as follows: Shares Weighted- (In thousands) Options outstanding at March 31, 2023 6,287 $ 4.11 Granted 266 4.06 Exercised (104) 3.22 Forfeited (403) 4.04 Expired (195) 4.85 Options outstanding at September 30, 2023 5,851 4.10 |
Schedule of Activity With Respect to RSUs | A summary of activity with respect to our RSUs, which entitle the holder to receive one share of our common stock for each RSU upon vesting, for the six months ended September 30, 2023 is as follows: Shares Weighted-Average (In thousands) RSUs outstanding at March 31, 2023 497 $ 4.12 Granted 274 4.08 Vested and released (80) 3.39 Forfeited (45) 4.12 RSUs outstanding at September 30, 2023 646 4.19 |
Schedule of Activity With Respect to PSUs | The following table summarizes the details of the performance stock units: Shares Weighted-Average (In thousands) PSUs outstanding at March 31, 2023 83 $ 4.45 Granted 223 2.60 Vested and released (43) 4.98 Forfeited (59) 3.61 PSUs outstanding at September 30, 2023 204 2.56 |
Schedule of Stock-based Compensation Expense | The following table presents stock-based compensation expense that is included in each line item on our unaudited condensed statements of operations: Three Months Ended Six Months Ended 2023 2022 2023 2022 (In thousands) Cost of revenues $ 58 $ 78 $ 143 $ 142 General and administrative 513 347 715 965 Sales and marketing 157 116 291 194 Research and development 144 155 247 243 Total stock-based compensation $ 872 $ 696 $ 1,396 $ 1,544 |
Description of Business and S_4
Description of Business and Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Mar. 31, 2023 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Capitalized contract fulfillment costs | $ 0.4 | $ 0.5 |
Description of Business and S_5
Description of Business and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) $ in Thousands | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Sep. 30, 2023 USD ($) customer | Sep. 30, 2022 customer | Sep. 30, 2023 USD ($) customer | Sep. 30, 2022 customer | Mar. 31, 2023 customer | |
Significant accounting policies | |||||
FDIC | $ | $ 250 | ||||
Deposits in excess of FDIC insured limit | $ | $ 20,100 | $ 20,100 | |||
No Individual Customer | Net Sales and Contract Revenues | Customer | |||||
Significant accounting policies | |||||
Number of customers | customer | 0 | 0 | 0 | 0 | |
Percentage of total net sales and contract revenues | 10% | 10% | 10% | 10% | |
No Individual Customer | Accounts Receivable | Customer | |||||
Significant accounting policies | |||||
Number of customers | customer | 0 | 0 | |||
Percentage of total net sales and contract revenues | 10% | 10% |
Description of Business and S_6
Description of Business and Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Mar. 31, 2022 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||
Cash and cash equivalents | $ 20,161 | $ 16,587 | $ 7,991 | |
Restricted cash | 449 | 140 | 141 | |
Cash, cash and cash equivalents and restricted cash | $ 20,610 | $ 16,727 | $ 8,132 | $ 23,809 |
Description of Business and S_7
Description of Business and Summary of Significant Accounting Policies - Property and Equipment (Details) - Property and Equipment | Sep. 30, 2023 |
Minimum | |
Significant accounting policies | |
Useful life | 3 years |
Maximum | |
Significant accounting policies | |
Useful life | 8 years |
Description of Business and S_8
Description of Business and Summary of Significant Accounting Policies - Goodwill and Long-Lived Assets (Details) | 6 Months Ended |
Sep. 30, 2023 segment | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of operating segments | 1 |
Number of reportable segments | 1 |
Description of Business and S_9
Description of Business and Summary of Significant Accounting Policies - Warranty (Details) | 6 Months Ended |
Sep. 30, 2023 | |
Minimum | |
Significant accounting policies | |
Warranty period | 1 year |
Maximum | |
Significant accounting policies | |
Warranty period | 3 years |
Description of Business and _10
Description of Business and Summary of Significant Accounting Policies - Immaterial Correction of Prior Period Financial Statements (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 |
Error Corrections and Prior Period Adjustments Restatement [Line Items] | ||||||
Accumulated deficit | $ 128,745 | $ 130,567 | ||||
Stockholders' equity | $ 67,566 | $ 65,807 | $ 62,906 | $ 63,866 | $ 70,374 | $ 75,250 |
Revision of Prior Period, Error Correction, Adjustment | ||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | ||||||
Accumulated deficit | 1,600 | |||||
Stockholders' equity | (1,600) | |||||
Previously Reported | ||||||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | ||||||
Accumulated deficit | 126,361 | |||||
Stockholders' equity | $ 65,479 |
Supplemental Financial Inform_3
Supplemental Financial Information - Inventories (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Raw materials | $ 7,771 | $ 7,840 |
Work in process | 106 | 315 |
Finished goods | 2,904 | 2,686 |
Total inventories | $ 10,781 | $ 10,841 |
Supplemental Financial Inform_4
Supplemental Financial Information - Property and Equipment (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Property and Equipment, net | ||
Accumulated depreciation | $ (6,130) | $ (5,886) |
Property and equipment, net | 1,325 | 1,297 |
Equipment | ||
Property and Equipment, net | ||
Gross | 6,631 | 6,359 |
Leasehold Improvements | ||
Property and Equipment, net | ||
Gross | $ 824 | $ 824 |
Supplemental Financial Inform_5
Supplemental Financial Information - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Property and Equipment, net | ||||
Depreciation | $ 100 | $ 100 | $ 286 | $ 308 |
Amortization of intangible assets | 800 | 800 | 1,570 | 1,626 |
Amortization recorded to cost of revenues | 100 | 100 | 300 | 300 |
Amortization of intangible assets | $ 651 | $ 651 | 1,302 | 1,319 |
Cost of revenues | ||||
Property and Equipment, net | ||||
Depreciation | 100 | 100 | ||
Operating Expenses | ||||
Property and Equipment, net | ||||
Depreciation | $ 200 | $ 200 |
Supplemental Financial Inform_6
Supplemental Financial Information - Intangible Assets (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Intangible Assets | ||
Gross Carrying Amount | $ 24,157 | $ 22,807 |
Accumulated Amortization | (14,189) | (12,617) |
Net Book Value | 9,968 | 10,190 |
Technology | ||
Intangible Assets | ||
Gross Carrying Amount | 4,986 | 4,986 |
Accumulated Amortization | (3,907) | (3,444) |
Net Book Value | 1,079 | 1,542 |
Customer contracts / relationships | ||
Intangible Assets | ||
Gross Carrying Amount | 9,550 | 9,550 |
Accumulated Amortization | (5,078) | (4,371) |
Net Book Value | 4,472 | 5,179 |
Trade names and non-compete agreements | ||
Intangible Assets | ||
Gross Carrying Amount | 782 | 782 |
Accumulated Amortization | (770) | (770) |
Net Book Value | 12 | 12 |
Capitalized software development costs | ||
Intangible Assets | ||
Gross Carrying Amount | 8,839 | 7,489 |
Accumulated Amortization | (4,434) | (4,032) |
Net Book Value | $ 4,405 | $ 3,457 |
Supplemental Financial Inform_7
Supplemental Financial Information - Future Estimated Amortization Expense (Details) $ in Thousands | Sep. 30, 2023 USD ($) |
Future estimated amortization expense | |
2024 | $ 1,796 |
2025 | 3,519 |
2026 | 2,295 |
2027 | 1,727 |
2028 | 619 |
Net Book Value | $ 9,956 |
Supplemental Financial Inform_8
Supplemental Financial Information - Warranty Reserve Activity (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Activity related to warranty reserve | ||
Balance at beginning of fiscal year | $ 758 | $ 616 |
Additions charged to cost of sales | 245 | 104 |
Warranty claims | (167) | (67) |
Balance at end of reporting period | $ 836 | $ 653 |
Supplemental Financial Inform_9
Supplemental Financial Information - Earnings (Loss) Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Sep. 30, 2023 | Jun. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Numerator: | ||||||
Net income (loss) | $ 551 | $ 2,125 | $ (7,397) | $ (4,865) | $ 2,676 | $ (12,262) |
Denominator: | ||||||
Weighted average common shares used in basic computation (in shares) | 42,742,000 | 42,288,000 | 42,654,000 | 42,334,000 | ||
Stock options and other dilutive awards (in shares) | 971,000 | 0 | 1,023,000 | 0 | ||
Weighted average common shares used in diluted computation (in shares) | 43,713,000 | 42,288,000 | 43,677,000 | 42,334,000 | ||
Net income (loss) per common share | ||||||
Basic net income (loss) per share (in dollars per share) | $ 0.01 | $ (0.17) | $ 0.06 | $ (0.29) | ||
Diluted net income (loss) per share (in dollars per share) | $ 0.01 | $ (0.17) | $ 0.06 | $ (0.29) |
Supplemental Financial Infor_10
Supplemental Financial Information - Loss per Share Excluded Weighted Average (Details) - shares shares in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Stock options | ||||
Shares excluded in the computation of loss from continuing operations per share | ||||
Shares excluded in the computation of loss from continuing operations per share | 3,213 | 5,534 | 3,287 | 5,626 |
Restricted stock units | ||||
Shares excluded in the computation of loss from continuing operations per share | ||||
Shares excluded in the computation of loss from continuing operations per share | 525 | 345 | 402 | 395 |
Restructuring Activities - Rest
Restructuring Activities - Restructuring Reserve (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Sep. 30, 2023 | Jun. 30, 2023 | |
Restructuring Reserve [Roll Forward] | ||
Restructuring reserve, beginning balance | $ 45 | $ 242 |
Cash payments | (45) | (197) |
Restructuring reserve, ending balance | $ 0 | $ 45 |
Fair Value Measurements - Narra
Fair Value Measurements - Narrative (Details) - USD ($) | Sep. 30, 2023 | Mar. 31, 2023 |
Fair Value Disclosures [Abstract] | ||
Non-financial assets measured at fair value | $ 0 | $ 0 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Mar. 31, 2023 | Sep. 30, 2023 | |
Assets: | ||
Amortized Cost | $ 1,426 | $ 1,598 |
Gross Unrealized Loss | (437) | (483) |
Gross Unrealized Gain | 321 | 427 |
Estimated Fair Value | 1,310 | 1,542 |
Liabilities: | ||
Amortized Cost | 1,201 | |
Gross Unrealized Loss | (296) | |
Gross Unrealized Gain | 563 | |
Estimated Fair Value | 1,468 | |
Level 1: | ||
Liabilities: | ||
Amortized Cost | 1,613 | |
Gross Unrealized Loss | (298) | |
Gross Unrealized Gain | 596 | |
Estimated Fair Value | 1,911 | |
Level 1: | Securities Held In Deferred Compensation Plan | ||
Assets: | ||
Amortized Cost | 1,426 | 1,598 |
Gross Unrealized Loss | (437) | (483) |
Gross Unrealized Gain | 321 | 427 |
Estimated Fair Value | 1,310 | 1,542 |
Level 1: | Deferred Compensation Plan Liabilities | ||
Liabilities: | ||
Amortized Cost | 1,201 | 1,613 |
Gross Unrealized Loss | (296) | (298) |
Gross Unrealized Gain | 563 | 596 |
Estimated Fair Value | 1,468 | $ 1,911 |
Level 3: | ||
Liabilities: | ||
Amortized Cost | 0 | |
Gross Unrealized Loss | 0 | |
Gross Unrealized Gain | 0 | |
Estimated Fair Value | 0 | |
Level 3: | Contingent Consideration | ||
Liabilities: | ||
Amortized Cost | 600 | |
Transfer out | (600) | |
Gross Unrealized Loss | 0 | |
Gross Unrealized Gain | 0 | |
Estimated Fair Value | $ 600 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Reconciliation of income tax (benefit) provision to taxes computed at U.S. federal statutory rates | ||||
Income tax (expense) benefit | $ 33 | $ (289) | $ (62) | $ (122) |
Effective income tax rate - (expense) benefit | 6.40% | (3.90%) | (2.30%) | (1.00%) |
Commitment and Contingencies (D
Commitment and Contingencies (Details) - USD ($) $ in Millions | 3 Months Ended | |
Jun. 30, 2023 | Aug. 07, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Estimated value of inventory to be returned | $ 0.8 | $ 1 |
Loss contingency | 0.2 | |
Inventory return, sale amount | $ 1 |
Right-of-Use Assets and Lease_3
Right-of-Use Assets and Lease Liabilities - Narrative (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Lease Costs | ||||
Lease costs | $ 600,000 | $ 600,000 | $ 1,200,000 | $ 1,300,000 |
Variable lease costs | $ 0 | $ 0 | $ 0 | $ 0 |
Minimum | ||||
Operating Leases | ||||
Renewal option term | 1 year | 1 year | ||
Maximum | ||||
Operating Leases | ||||
Renewal option term | 5 years | 5 years |
Right-of-Use Assets and Lease_4
Right-of-Use Assets and Lease Liabilities - Related Assets and Liabilities on the Balance Sheet (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Assets | ||
Total operating lease right-of-use-assets | $ 7,509 | $ 8,345,000 |
Liabilities | ||
Operating lease liabilities (short-term) | $ 2,319 | $ 2,339 |
Operating lease, liability, current, statement of financial position | Accrued liabilities | Accrued liabilities |
Operating lease liabilities (long-term) | $ 6,560 | $ 7,641 |
Total lease liabilities | $ 8,879 | $ 9,980 |
Right-of-Use Assets and Lease_5
Right-of-Use Assets and Lease Liabilities - Supplemental Information (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Supplemental Information | ||
Cash paid for amounts included in the measurement of operating lease liabilities (in thousands) | $ 1,346 | $ 706 |
Weighted average remaining lease term (in years) | 3 years 6 months | 4 years 3 months 18 days |
Weighted average discount rate | 4.70% | 4.80% |
Right-of-Use Assets and Lease_6
Right-of-Use Assets and Lease Liabilities - Undiscounted Cash Flows (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Operating Leases | ||
2024 | $ 1,348 | |
2025 | 2,483 | |
2026 | 2,178 | |
2027 | 2,207 | |
2028 | 1,315 | |
Thereafter | 204 | |
Total lease payments | 9,735 | |
Less imputed interest | (856) | |
Total lease liabilities | 8,879 | $ 9,980 |
Less current obligations under leases | (2,319) | (2,339) |
Lease liabilities | $ 6,560 | $ 7,641 |
Stock-Based Compensation - Stoc
Stock-Based Compensation - Stock Options (Details) | 6 Months Ended |
Sep. 30, 2023 plan $ / shares shares | |
Stock-Based Compensation | |
Number of stock incentive plans | plan | 2 |
Vested and expected to vest at the end of the period (in shares) | 5,900,000 |
Stock options | |
Shares | |
Options outstanding at the beginning of the period (in shares) | 6,287,000 |
Granted (in shares) | 266,000 |
Exercised (in shares) | (104,000) |
Forfeited (in shares) | (403,000) |
Expired (in shares) | (195,000) |
Options outstanding at the end of the period (in shares) | 5,851,000 |
Weighted- Average Exercise Price | |
Options outstanding at the beginning of the period (in dollars per share) | $ / shares | $ 4.11 |
Granted (in dollars per share) | $ / shares | 4.06 |
Exercised (in dollars per share) | $ / shares | 3.22 |
Forfeited (in dollars per share) | $ / shares | 4.04 |
Expired (in dollars per share) | $ / shares | 4.85 |
Options outstanding at the end of the period (in dollars per share) | $ / shares | $ 4.10 |
2016 Plan | |
Stock-Based Compensation | |
Authorized for future issuance under stock incentive plans (in shares) | 1,700,000 |
Stock-Based Compensation - Rest
Stock-Based Compensation - Restricted Stock Units (Details) - Restricted stock units | 6 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of shares of common stock receivable upon vesting of each RSU (in shares) | 1 |
Shares | |
Options outstanding at the beginning of the period (in shares) | 497,000 |
Granted (in shares) | 274,000 |
Vested (in shares) | (80,000) |
Forfeited (in shares) | (45,000) |
Options outstanding at the end of the period (in shares) | 646,000 |
Weighted-Average Grant Date Fair Value | |
Options outstanding at the beginning of the period (in dollars per share) | $ / shares | $ 4.12 |
Granted (in dollar per share) | $ / shares | 4.08 |
Vested (in dollars per share) | $ / shares | 3.39 |
Forfeited (in dollars per share) | $ / shares | 4.12 |
Options outstanding at the end of the period (in dollars per share) | $ / shares | $ 4.19 |
Stock-Based Compensation - Perf
Stock-Based Compensation - Performance Stock Units (Details) shares in Thousands | 6 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Maximum achievement percentage | 2 |
Performance Stock Units | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Performance period | 3 years |
Service period | 3 years |
Shares | |
Options outstanding at the beginning of the period (in shares) | shares | 83 |
Granted (in shares) | shares | 223 |
Vested (in shares) | shares | (43) |
Forfeited (in shares) | shares | (59) |
Options outstanding at the end of the period (in shares) | shares | 204 |
Weighted-Average Grant Date Fair Value | |
Options outstanding at the beginning of the period (in dollars per share) | $ / shares | $ 4.45 |
Granted (in dollar per share) | $ / shares | 2.60 |
Vested (in dollars per share) | $ / shares | 4.98 |
Forfeited (in dollars per share) | $ / shares | 3.61 |
Options outstanding at the end of the period (in dollars per share) | $ / shares | $ 2.56 |
Minimum | Performance Stock Units | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting percentage | 0% |
Maximum | Performance Stock Units | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Vesting percentage | 160% |
Stock-Based Compensation - St_2
Stock-Based Compensation - Stock Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Stock-Based Compensation | ||||
Total stock-based compensation | $ 872 | $ 696 | $ 1,396 | $ 1,544 |
Stock options | ||||
Stock-Based Compensation | ||||
Unrecognized compensation expense related to unvested stock options | 3,200 | $ 3,200 | ||
Weighted average period over which compensation expense is expected to be recognized | 2 years 6 months | |||
Restricted stock units | ||||
Stock-Based Compensation | ||||
Unrecognized compensation expense related to unvested RSUs | 1,600 | $ 1,600 | ||
Weighted average period over which compensation expense is expected to be recognized | 1 year 8 months 12 days | |||
Phantom Share Units (PSUs) | ||||
Stock-Based Compensation | ||||
Unrecognized compensation expense related to unvested RSUs | 300 | $ 300 | ||
Weighted average period over which compensation expense is expected to be recognized | 2 years 1 month 6 days | |||
Cost of revenues | ||||
Stock-Based Compensation | ||||
Total stock-based compensation | 58 | 78 | $ 143 | 142 |
General and administrative | ||||
Stock-Based Compensation | ||||
Total stock-based compensation | 513 | 347 | 715 | 965 |
Sales and marketing | ||||
Stock-Based Compensation | ||||
Total stock-based compensation | 157 | 116 | 291 | 194 |
Research and development | ||||
Stock-Based Compensation | ||||
Total stock-based compensation | $ 144 | $ 155 | $ 247 | $ 243 |
Stock-Based Compensation - Othe
Stock-Based Compensation - Other Stock-Based Compensation Plans (Details) $ in Thousands | 1 Months Ended | ||
Jan. 01, 2018 USD ($) offeringPeriod | Jul. 31, 2023 shares | Jul. 31, 2022 shares | |
Other Stock-Based Compensation Plans | |||
Number of shares purchased (in shares) | shares | 92,097 | 84,426 | |
ESPP | |||
Other Stock-Based Compensation Plans | |||
Purchase price of common stock | 95% | ||
Number of offering periods | offeringPeriod | 2 | ||
Duration of offering period | 6 months | ||
Annual stock value | $ | $ 30 | ||
ESPP | Minimum | |||
Other Stock-Based Compensation Plans | |||
Employer matching contribution | 1% | ||
ESPP | Maximum | |||
Other Stock-Based Compensation Plans | |||
Employer matching contribution | 15% |
Stock-Based Compensation - Defe
Stock-Based Compensation - Deferred Compensation Plan (Details) | Oct. 01, 2020 plan |
Share-Based Payment Arrangement [Abstract] | |
Number of deferred compensation plans | 2 |
Stock Repurchase Program (Detai
Stock Repurchase Program (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |||
May 12, 2022 | Nov. 06, 2014 | Sep. 30, 2023 | Aug. 09, 2012 | |
August 2012 Program | ||||
Stock Repurchase Program | ||||
Value of common stock approved under stock repurchase program | $ 3 | |||
Increase in the authorized amount for repurchase of common stock | $ 3 | |||
Number of shares acquired | 2,458,000 | |||
Value of common stock repurchased | $ 4.3 | |||
Average price per share of common stock repurchased (in dollars per share) | $ 1.73 | |||
May 2022 Program | ||||
Stock Repurchase Program | ||||
Value of common stock approved under stock repurchase program | $ 10 | |||
Treasury stock retirement (in shares) | 300,000 | |||
Value of common stock available for repurchase under current program | $ 9.1 |
Business Segments - Narrative (
Business Segments - Narrative (Details) | 6 Months Ended |
Sep. 30, 2023 segment | |
Segment Reporting [Abstract] | |
Number of reportable segments | 1 |
Long-Term Debt (Details)
Long-Term Debt (Details) - Revolving Credit Facility - Line of Credit - USD ($) $ in Millions | Sep. 12, 2022 | Jan. 25, 2022 |
Subsequent Event [Line Items] | ||
Maximum borrowing capacity | $ 20 | |
Increase limit in revolving commitments | $ 40 | |
Leverage ratio, maximum | 300% | |
Leverage ratio, minimum | 100% | |
Fixed charge coverage ratio, maximum | 125% | |
Fixed charge coverage ratio, minimum | 100% | |
Amortization of deferred financing costs and commitment fees | $ 0.3 | |
Minimum | ||
Subsequent Event [Line Items] | ||
Unused commitment fee percentage | 0.25% | |
Minimum | SOFR | ||
Subsequent Event [Line Items] | ||
Basis spread on variable rate | 2% | |
Minimum | Base Rate | ||
Subsequent Event [Line Items] | ||
Basis spread on variable rate | 1% | |
Maximum | ||
Subsequent Event [Line Items] | ||
Unused commitment fee percentage | 0.35% | |
Maximum | SOFR | ||
Subsequent Event [Line Items] | ||
Basis spread on variable rate | 2.80% | |
Maximum | Base Rate | ||
Subsequent Event [Line Items] | ||
Basis spread on variable rate | 1.80% |